Explore Business Standard
Crisil, an S&P Global Company, announced the acquisition of McKinsey PriceMetrix Co. (PriceMetrix), a leading provider of performance benchmarking and data-driven insights for the wealth management industry. PriceMetrix, based in Toronto, serves leading wealth management firms in the US and Canada. Its proprietary database covers USD 8 trillion in assets under management and 30 million investment accounts, backed by 25 years of data, rating agency Crisil said in a statement. The acquisition includes key products such as ValueOne, FeeCheck, CommissionCheck, SignalOne, advisory services, and comprehensive surveys of the North American wealth management sector, it said. This planned acquisition aligns with Crisil's strategy to scale in wealth management and extend sector benchmarking capabilities to large global banks, traditional wealth managers, and registered investment advisors (RIAs), it said. With this acquisition, Crisil strengthens its position as a leading provider of ...
McKinsey & Company consulting firm has agreed to pay USD 650 million to settle a federal investigation into its work to help opioids manufacturer Purdue Pharma boost the sales of the highly addictive drug OxyContin, according to court papers filed in Virginia on Friday. As part of the deal with the US Justice Department, McKinsey will avoid prosecution on criminal charges if it pays the sum and follows certain conditions for five years, including ceasing any work on the sale, marketing or promotion of controlled substances. A former McKinsey senior partner, Martin Elling, has also agreed to plead guilty to obstruction of justice for deleting documents from his laptop after he became aware of investigations into Purdue Pharma, the maker of OxyContin that was then a client, according to the filings. A lawyer for Elling declined to comment Friday. McKinsey said in a statement on Friday that it's deeply sorry for its work for Purdue Pharma. We should have appreciated the harm opioids .